TMCnet News
Markets and Markets : Label-Free Detection Market (Bio-layer interferometry, Optical waveguide grating technology, Surface Plasmon resonance) worth $1,708.23 Million by 2018(M2 PressWIRE Via Acquire Media NewsEdge) The "Label-Free Detection Market by Technology (Bio-layer interferometry, Optical waveguide grating technology, Surface Plasmon resonance), Consumables & Instruments, Applications (Lead Generation, Binding Kinetics), End user - Global Forecasts & Trends to 2018" report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global label-free detection market along with the estimates and forecasts of the revenue and share analysis. Browse 107 market data Tables and 38 Figures spread through 235 Pages and in-depth TOC on "Label-Free Detection Market". http://www.marketsandmarkets.com/Market-Reports/label-free-detection-market-32435593.html This report studies the global label-free detection market over the forecast period of 2013 to 2018. This market is valued at an estimated $1,708.23 million in 2013. The report segments this market by technology, application, product, end user, and geography. The technology segments included in this report are bio-layer interferometry (BLI), cellular dielectric spectroscopy, optical waveguide grating technology (OWG), surface plasmon resonance (SPR), and other technologies. Of these, the surface plasmon resonance technology segment commanded the largest share of the global label-free detection market in 2013 and is also poised to grow at the healthy CAGR between 2013 and 2018. However, bio-layer interferometry segment is will grow at the highest CAGR between 2013 and 2018. The advantage of not using any labels or reporter molecules for detection along with increasing application of biomolecular interaction analysis in drug discovery are driving the growth of this technology segment. Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=32435593 The application segments included in this report are binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation, and other application segments. The binding kinetics application segment commanded the largest share of the global label-free detection market in 2013, while the hit confirmation segment is poised to grow at the highest CAGR between 2013 and 2018. The binding kinetic studies measure drug residence time, which are important for predicting clinical outcome of drug candidates. As such, the development in drug discovery will boost the binding kinetics studies and drive the label-free detection market. Based on geography, the global Label-Free Detection Market is segmented into geographic segments of Asia, Europe, North America, and the Rest of the World (RoW). Asia is segmented into regional segments of China, India, Japan and Rest of Asia. Europe is segmented into Germany, France, Italy, Spain, the U.K., and the Rest of Europe North America is segmented into the Canada and U.S., while the regional segments in Rest of World are Latin America, Middle East & Africa, and Pacific. Further Inquiry: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=32435593 Label-free detection is a very well accepted drug discovery tool in the pharmaceutical & biotech industry and academic research. It helps in the investigation of biomolecular interactions without auto-fluorescent, spatial-interference, or quenching effects of labels. Increasing drug discovery programs by pharmaceutical companies and academic institutes will drive the growth of this market between 2013 and 2018. However, increasing market consolidation and high cost of instruments and consumables will restrain the growth of this market. The major players in the label-free detection market are Ametek, Inc. (U.S.), Attana AB (Sweden), Bio-Rad Laboratories, Inc. (U.S.), BiOptix (USA), Corning, Inc. (U.S.), Danaher Corporation (U.S.), General Electric Corporation (U.S.), Pall Corporation (U.S.), PerkinElmer (U.S.), Roche (Switzerland), and X-BODY Bioscience (U.S.). Browse related reports High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018 http://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018 http://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, healthcare information technology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, agriculture industry, semiconductor and electronics, aerospace & defense. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Contact: Mr. Rohan North - Dominion Plaza 17304 Preston Road Suite 800, Dallas, TX 75252 Tel: +1-888-600-6441 Email: [email protected] Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets CONTACT: Rohan 8886006441 [email protected] . (c) 2014 M2 COMMUNICATIONS |